National Cancer Institute

TitleKeywordsActivity CodeFOALOI Due DateApplication Due Date
(NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environmentsprevention, controlR01, R03, R21NOT-CA-25-0121/8/2028
(NOSI): Advancing Diet and Physical Activity Biomarkers for Assessing Lifestyle Interventions in Cancer Prevention and Cancer Interception Researchbiomarkers, lifestyle interventions, prevention, interception, diet, physical activityR01, R03, R21NOT-CA-24-0741/8/2027
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)Exploratory, Early-stage, cancer control, novel, ESIR21PA-25-25310/16/2026
(NOSI): NCI's Interest in Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatmentmultidisciplinary, collaborationNOT-CA-25-0071/8/2028
(NOSI): Survivorship Research for People Living with Advanced and Metastatic Cancerspalliative, quality-of-life, psychosocialNOT-CA-25-0241/8/2028
(NOSI): Communication and Decision-Making in a Complex and Dynamic Cancer Treatment Environmentenvironment, patient-providerNOT-CA-25-0069/8/2028
(NOSI): Mechanisms Driving Obesity and Prostate Cancer Riskprostate, risk, preventionR00, R01, R21, K99NOT-CA-25-0021/8/2028
(NOSI): Research on rare cancers across the cancer control continuumtreatment, diagnosis, epidemiologyR01, R03, R21, R34, U34, P01NOT-CA-25-0101/8/2028
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)molecular, biomarkers, therapies, clinical UH2, UH3PAR-25-07410/15/2026
NCMRR Early Career Research Award (R03 Clinical Trial Optional)Biomedical Informatics, Cancer Informatics, Health Data Management, Cancer ResearchR03PAR-25-1246/18/0275
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)molecular, biomarkers, therapies, clinical UH3PAR-25-07510/15/2026
Clinical Characterization of Cancer Therapy - induced Adverse Sequelae and Mechanism - based Interventional Strategies (R01 Clinical Trial Optional)collaborative, therapies, basic, translational, clinical, biomarkers, R01PAR-25-1459/5/202610/5/2026
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)dissemination, implementation, evidence-based interventions, publicR01PAR-25-1449/5/202610/5/2026
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)Systems-level, mechanisms of responses. Therapy, novel, data, collaborativeU01PAR-26-1349/5/202610/5/2026
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research (K12 Clinical Trial Optional)career development, prevention, population, clinical trial, mentorship, communityK12PAR-24-1532/18/2027
NCI Pathway to Independence Award for Early - Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required)Limited, early-stage, postdoctoral, cancer control, cancer prevention, data scienceK99, R00PAR-23-28810/14/2026
NCI Pathway to Independence Award for Early - Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)Limited, early-stage, postdoctoral, cancer control, cancer prevention, data scienceK99, R00PAR-23-28610/14/2026
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)Translational, clinical trial, treatment, therapy, imaging, radiation, alternative, therapeutic, interventional, innovativeR01PAR-25-08110/5/2026
Cancer Prevention Fellowship ProgramFellowship, training, career development, postdoctoral8/6/2026
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)Community, engagement, population, healthcare, prevention, collaborationUG1RFA-CA-27-0089/18/2026
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)bioinformatics, software, clinical data, computational, infrastructure, technologyU24RFA-CA-27-02010/19/2026
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)Informatics, clinical trial, software, technology development, data management, research toolsU24RFA-CA-27-02110/19/2026
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)prototype, novel, software, computational, data analytics, technology, innovation, feasibility testingRFA-CA-27-01910/19/2026
Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)postdoctoral, training, career development, mentorship, workforceK32PAR-27-06210/12/2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)technology, prototype, assay development, diagnostic, translational, innovationR33RFA-CA-27-00211/10/2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)prototype, feasibility, engineering, innovation, novel, assay, technology, innovation, translationalR61RFA-CA-27-00111/10/2026
Metastasis Research Network (U54 Clinical Trial Not Allowed)tumor, microenvironment, dormancy, biology, multidisciplinary, collaboration, mechanisticU54RFA-CA-27-0129/25/2026
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)clinician scientist, mentorship, career development, translational, academic, patient orientedK12PAR-27-02510/12/2026
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)prevention, behavioral, interventions, screening, symptom management, quality of life, implementationR34PAR-25-10410/25/2026
NCI Immunotherapy FellowshipFellowship, training, career development, postdoctoral8/12/2026

Can’t find what you’re looking for? Please contact researchdevelopment@cancer.ufl.edu for assistance in finding additional funding opportunities.

NCI Cancer Center badge